Safety of using glucagon-like peptide-1 receptor agonists before gastrointestinal endoscopy： an overview of systematic reviews

LI Yuzhou; ZOU Shuying; ZHU Xiangnan; TANG Li; LI Peng; XIE Caixia

doi:10.6039/j.issn.1001-0408.2026.06.19

您当前的位置：

首页 >

文章列表页 >

Safety of using glucagon-like peptide-1 receptor agonists before gastrointestinal endoscopy： an overview of systematic reviews

更新时间：2026-03-26

- Safety of using glucagon-like peptide-1 receptor agonists before gastrointestinal endoscopy： an overview of systematic reviews
- ZHONGGUO YAOFANG Vol. 37, Issue 6, Pages: 806-811(2026)
- 作者机构：
  
  1.电子科技大学医学院，成都;610054
  2.成都中医药大学护理学院，成都　610075
  3.四川省医学科学院·四川省人民医院（电子科技大学附属医院）麻醉手术中心，成都　610072
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2026.06.19
  CLC： R969.3
- Received：10 November 2025，
  
  Revised：2026-03-05，
  
  Accepted：06 March 2026，
  
  Published：30 March 2026
- 稿件说明：
移动端阅览
李雨舟,邹淑英,朱湘南,等.消化道内镜检查前使用胰高血糖素样肽1受体激动剂的安全性系统评价再评价 [J].中国药房,2026,37(06):806-811.

LI Yuzhou,ZOU Shuying,ZHU Xiangnan,et al.Safety of using glucagon-like peptide-1 receptor agonists before gastrointestinal endoscopy： an overview of systematic reviews[J].ZHONGGUO YAOFANG,2026,37(06):806-811.
李雨舟,邹淑英,朱湘南,等.消化道内镜检查前使用胰高血糖素样肽1受体激动剂的安全性系统评价再评价 [J].中国药房,2026,37(06):806-811. DOI： 10.6039/j.issn.1001-0408.2026.06.19.

LI Yuzhou,ZOU Shuying,ZHU Xiangnan,et al.Safety of using glucagon-like peptide-1 receptor agonists before gastrointestinal endoscopy： an overview of systematic reviews[J].ZHONGGUO YAOFANG,2026,37(06):806-811. DOI： 10.6039/j.issn.1001-0408.2026.06.19.

摘要

目的

系统评价消化道内镜检查前使用胰高血糖素样肽1受体激动剂（GLP-1RA）的安全性。

方法

检索中国知网、万方数据、维普网、中国生物医学文献数据库、PubMed等中英文数据库，收集消化道内镜检查前使用GLP-1RA的安全性的系统评价和Meta分析，检索时限为建库至2025年9月30日。通过PRISMA 2020声明、AMSTAR 2量表、ROBIS工具、GRADE工具分别进行报告质量、方法学质量、偏倚风险和证据质量评价，同时利用修正覆盖面积（CCA）定量评价结局指标的文献重叠程度，并对系统评价/Meta分析的定量结果进行综合质量分析。

结果

共纳入10篇文献。10项研究均存在一定的信息缺陷（15.5～19.5分），且均存在高偏倚风险；9项研究的方法学质量为极低级，1项研究为低级；在证据质量方面，88个结局指标中，1个为中级、28个为低级、59个为极低级；残留胃内容物发生率、误吸发生率、内镜检查中断发生率、重复内镜检查发生率、肠道准备不足发生率以及波士顿肠道准备量表评分的CCA分别为37.30%、35.00%、35.00%、50.00%、29.60%和20.00%。综合质量分析结果显示，与对照组比较，干预组患者的残留胃内容物发生率、内镜检查中断发生率、重复内镜检查发生率均显著升高，胃排空时间显著延长，波士顿肠道准备量表评分显著降低（

＜0.05），但关于GLP-1RA对患者误吸发生率和肠道准备不足发生率影响的研究结果并不一致。

结论

消化道内镜检查前使用GLP-1RA会增加患者的残留胃内容物、内镜检查中断和重复内镜检查的发生风险，延长胃排空时间，并降低肠道准备质量，但其对患者误吸和肠道准备不足的影响尚存争议。因纳入系统评价/Meta分析的报告质量、方法学质量及证据质量低，且偏倚风险高，故需谨慎解读所得结论。

Abstract

OBJECTIVE

To conduct a systematic review concerning the safety of using glucagon-like peptide-1 receptor agonists （GLP-1RA） before gastrointestinal endoscopy.

METHODS

Chinese and English databases including CNKI， Wanfang Data， VIP， CBM， and PubMed were searched to collect systematic reviews and meta-analyses on the safety of using GLP-1RA before gastrointestinal endoscopy， with a search period from the inception to September 30， 2025. Report quality， methodological quality， risk of bias， and evidence quality were assessed using the PRISMA 2020 statement， AMSTAR 2 scale， ROBIS tool， and GRADE tool， respectively. Corrected covered area （CCA） was used to quantitatively evaluate the degree of outcome overlap， and a comprehensive quality analysis was performed on the quantitative results of systematic reviews/meta-analyses.

RESULTS

Ten studies were included. All 10 stu

dies had some information deficiencies （15.5-19.5 points）， and were at high risk of bias； 9 studies were extremely low methodological quality， while 1 study was low. In terms of evidence quality， among 88 outcome indexes， there was 1 moderate-level index， 28 low-level indexes， and 59 extremely low-level indexes. The CCA values of the incidence of residual gastric contents， aspiration， endoscopy interruption， repeated endoscopy， inadequate bowel preparation and Boston Bowel Preparation Scale scores were 37.30%， 35.00%， 35.00%， 50.00%， 29.60% and 20.00%， respectively. Results of comprehensive quality analysis showed that compared with the control group， the incidence of residual gastric contents， endoscopy interruption and repeated endoscopy were increased significantly in the intervention group， along with a notably prolonged gastric emptying time and a significantly lower score of Boston Bowel Preparation Scale （

＜0.05）. However， the study results regarding the effects of GLP-1RA on the incidence of aspiration and inadequate bowel preparation were inconsistent.

CONCLUSIONS

The use of GLP-1RA before gastrointestinal endoscopy can increase certain safety risks， including residual gastric contents， endoscopy interruption and repeated endoscopy， prolong gastric emptying time， and reduce the quality of bowel preparation. However， the effects on aspiration and inadequate bowel preparation remain controversial. The reports included in systematic reviews/meta-analyses exhibited low quality in reporting， methodology and evidence， with high risk of bias. Therefore， conclusions should be interpreted with caution.

关键词

Keywords

references

潘琦，郭立新 . 胰高糖素样肽-1受体激动剂的发展历程和临床应用进展 [J ] . 中华糖尿病杂志， 2022 ， 14 （ 12 ）： 1355 - 1363 .

JALLEH R J ， RAYNER C K ， HAUSKEN T ， et al . Gastrointestinal effects of GLP-1 receptor agonists：mechanisms，management，and future directions [J ] . Lancet Gastroenterol Hepatol ， 2024 ， 9 （ 10 ）： 957 - 964 .

王婷，王萍，尚鑫，等 . 胰高血糖素样肽-1受体激动剂降低血糖、减轻体重外的获益分析 [J ] . 中国新药与临床杂志， 2025 ， 44 （ 11 ）： 830 - 836 .

USHAKUMARI D S ， SLADEN R N . ASA consensus-based guidance on preoperative management of patients on glucagon-like peptide-1 receptor agonists [J ] . Anesthesi-ology ， 2024 ， 140 （ 2 ）： 346 - 348 .

HASHASH J G ， THOMPSON C C ， WANG A Y . AGA rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy：communication [J ] . Clin Gastroenterol Hepatol ， 2024 ， 22 （ 4 ）： 705 - 707 .

LI X Y ， JIN Y ， FENG X Y ， et al . Perioperative management of patients on GLP-1 receptor agonists：risks，recom-mendations，and future directions：a narrative review [J ] . J Clin Anesth ， 2025 ， 104 ： 111871 .

TARAR Z I ， FAROOQ U ， CHAUDHRY A ， et al . Evidence report on the safety of gastrointestinal endoscopy in patients on glucagon-like peptide-1 receptor agonists：a systematic review and meta-analysis [J ] . Diagnostics ， 2025 ， 15 （ 6 ）： 770 .

FACCIORUSSO A ， RAMAI D ， DHAR J ， et al . Effects of glucagon-like peptide-1 receptor agonists on upper gastrointestinal endoscopy：a meta-analysis [J ] . Clin Gastroenterol Hepatol ， 2025 ， 23 （ 5 ）： 715 - 725.e3 .

SINGH S ， RAHMAN S H ， KHAN N ， et al . Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes：systematic review and meta-analysis [J ] . Gastrointest Endosc ， 2025 ， 101 （ 2 ）： 343 - 349.e5 .

AROMATARIS E ， FERNANDEZ R ， GODFREY C M ， et al . Summarizing systematic reviews：methodological development，conduct and reporting of an umbrella review approach [J ] . Int J Evid Based Healthc ， 2015 ， 13 （ 3 ）： 132 - 140 .

PAGE M J ， MOHER D ， BOSSUYT P M ， et al . PRISMA 2020 explanation and elaboration：updated guidance and exemplars for reporting systematic reviews [J ] . BMJ ， 2021 ， 372 ： n160 .

SHEA B J ， REEVES B C ， WELLS G ， et al . AMSTAR 2：a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions，or both [J ] . BMJ ， 2017 ， 358 ： j4008 .

WHITING P ， SAVOVIĆ J ， HIGGINS J P T ， et al . ROBIS：a new tool to assess risk of bias in systematic reviews was developed [J ] . J Clin Epidemiol ， 2016 ， 69 ： 225 - 234 .

SCHÜNEMANN H J ， BRENNAN S ， AKL E A ， et al . The development methods of official GRADE articles and requirements for claiming the use of GRADE：a statement by the GRADE guidance group [J ] . J Clin Epidemiol ， 2023 ， 159 ： 79 - 84 .

PIEPER D ， ANTOINE S L ， MATHES T ， et al . Systematic review finds overlapping reviews were not mentioned in every other overview [J ] . J Clin Epidemiol ， 2014 ， 67 （ 4 ）： 368 - 375 .

ABDULRAHEEM A ， ABUJABER B ， AYERS L ， et al . Impact of GLP-1 receptor agonists on upper gastrointestinal endoscopy：an updated systematic review and meta-analysis [J ] . Surg Endosc ， 2025 ， 39 （ 8 ）： 5135 - 5151 .

AHMED Z ， IQBAL A ， ARIF S F ， et al . Bowel preparation quality in patients using glucagon-like peptide-1 agonists：a systematic review and meta-analysis [J ] . Gastrointest Endosc ， 2026 ， 103 （ 2 ）： 235 - 240.e5 .

BAIG M U ， PIAZZA A ， LAHOOTI A ， et al . Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy：a systematic review and a meta-analysis [J ] . Gastrointest Endosc ， 2025 ， 101 （ 4 ）： 762 - 771.e13 .

BERAN A ， NAYFEH T ， AKHRAS A ， et al . Effect of glucagon-like peptide-1 receptor agonists on bowel preparation for colonoscopy：a systematic review and meta-analysis [J ] . Am J Gastroenterol ， 2025 ， 120 （ 7 ）： 1653 - 1656 .

CHIU Y T ， CHEN Y T ， LEE F J ， et al . The impact of glucagon-like peptide-1 receptor agonists on the quality indicators of colonoscopy：a systematic review and meta-analysis [J ] . Dig Liver Dis ， 2025 ， 57 （ 7 ）： 1386 - 1392 .

ELMATI P R ， JAGIRDHAR G S K ， QASBA R K ， et al . GLP-1 agonists and the risk of pulmonary aspiration during elective upper endoscopy：a systematic review and meta-analysis [J ] . Open Respir Med J ， 2025 ， 19 ： e187430-64372550 .

TAN Y ， ZHANG X ， LV X H ， et al . Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy：a meta-analysis [J ] . Dig Liver Dis ， 2025 ， 57 （ 7 ）： 1377 - 1385 .

MILDER D A ， MILDER T Y ， LIANG S S ， et al . Glucagon-like peptide-1 receptor agonists：a narrative review of clinical pharmacology and implications for peri-operative practice [J ] . Anaesthesia ， 2024 ， 79 （ 7 ）： 735 - 747 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

JAK Inhibitors Therapy for Rheumatoid Arthritis ：An Overview of Systematic Reviews

Efficacy and safety of omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children

Efficacy and safety of Tripterygium wilfordii polyglycoside combined with finerenone in the treatment of diabetic nephropathy

Efficacy and safety of immune checkpoint inhibitors combined with neoadjuvant chemotherapy in the treatment of early triple-negative breast cancer： a meta-analysis

Meta-analysis of the efficacy and safety total glucosides of paeonia in the treatment of systemic lupus erythematosus

Related Author

WANG Haikun

WANG Jie

WU Na

LI Cunming

LIN Ziwei

WU Wei

ZHU Qingmei

WANG Jing

Related Institution

School of Pharmacy， Xinjiang Medical University

Dept. of Public Health and Infection Management， Sixth People’s Hospital of Xinjiang Uygur Autonomous Region

Dept. of Pharmacy/Key Laboratory of Clinical Drug Research in Xinjiang， the First Affiliated Hospital of Xinjiang Medical University

Dept. of Cardiology， Handan Shengji Cancer Hospital

Dept. of Neurosurgery， Xingtai Central Hospital

⁰